Sonnet Biotherapeutics has received shareholder approval to merge with Hyperliquid Strategies Inc

2025-12-02 22:26:45

Collection

According to market news, Nasdaq-listed biotech company Sonnet Biotherapeutics has received shareholder approval to merge with Hyperliquid Strategies Inc.

Previously, it was reported that Hyperliquid Strategies submitted an S-1 filing to raise up to $1 billion, which may be used to purchase HYPE tokens.

(Source Link)

Risk warning

2026-02-12 23:40

The giant whale 3NVeXm transferred 1,800 bitcoins to Binance, worth approximately 122 million USD

2026-02-12 23:31

Japanese digital financial platform PayPay submits IPO application in the United States

2026-02-12 23:26

Lighter has reached an agreement with Circle to share the earnings generated from approximately $920 million USDC deposits on the platform

2026-02-12 22:59